Related Experiment Videos
Cefotaxime in caesarian sections in patients with chorioamniotitis
The Journal of Antimicrobial Chemotherapy
|September 1, 1984
Summary
Cefotaxime effectively treated chorioamniotitis in women undergoing Caesarian section. This antibiotic led to complete recovery in 96% of patients with mixed bacterial infections.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Pharmacology
Background:
- Chorioamniotitis is a serious infection during pregnancy.
- Mixed aerobic and anaerobic bacterial infections pose treatment challenges.
- Caesarean section delivery in the presence of infection requires effective antimicrobial therapy.
Purpose of the Study:
- To evaluate the efficacy of cefotaxime in treating chorioamniotitis in women undergoing Caesarian section.
- To assess the recovery rate associated with cefotaxime treatment for mixed bacterial infections.
Main Methods:
- A cohort of fifty women with Caesarian section and chorioamniotitis were enrolled.
- Treatment involved daily administration of cefotaxime at a dosage of 4 grams.
- Infection was characterized by the presence of mixed aerobic and anaerobic bacteria.
Main Results:
- Complete recovery was observed in 96% of the treated women.
- Cefotaxime demonstrated high efficacy in resolving chorioamniotitis.
- The treatment was well-tolerated, leading to successful outcomes in the majority of cases.
Conclusions:
- Cefotaxime is an effective antibiotic for treating chorioamniotitis in women undergoing Caesarian section.
- The drug is highly successful in managing mixed aerobic and anaerobic bacterial infections.
- This regimen offers a high recovery rate for a significant obstetric complication.